T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
C
|
Comcast Corp
F:CTP2
|
US |
Bankruptcy Probability
T Man Pharmaceutical PCL's probability of bankruptcy is 2.6%, pointing to a small but noticeable default risk. The solvency score is 57/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Mar 31, 2026 | 915.7m |
| Dec 31, 2025 | 751.6m |
| Sep 30, 2025 | 643.4m |
| Jun 30, 2025 | 797.2m |
| Mar 31, 2026 | 40.3m |
| Dec 31, 2025 | 40.4m |
| Sep 30, 2025 | 240.5m |
| Jun 30, 2025 | 240.6m |
| Mar 31, 2026 | 914.3m |
| Dec 31, 2025 | 938.3m |
| Sep 30, 2025 | 954.5m |
| Jun 30, 2025 | 1B |
Solvency Ratios
Solvency Ratios Comparison
T Man Pharmaceutical PCL Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TH |
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
4.2B THB |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
366.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
212.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
180.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
T Man Pharmaceutical PCL's probability of bankruptcy is 2.6%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, T Man Pharmaceutical PCL has total debt of 914.3m THB. This includes both short-term (850m THB) and long-term (64.3m THB) debt.
You can find a full breakdown on its Balance Sheet.
